The p38MAPK inhibitor SB203580 alleviates ultraviolet-induced phosphorylation at serine 389 but not serine 15 and activation of p53

Citation
D. Keller et al., The p38MAPK inhibitor SB203580 alleviates ultraviolet-induced phosphorylation at serine 389 but not serine 15 and activation of p53, BIOC BIOP R, 261(2), 1999, pp. 464-471
Citations number
54
Categorie Soggetti
Biochemistry & Biophysics
Journal title
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
ISSN journal
0006291X → ACNP
Volume
261
Issue
2
Year of publication
1999
Pages
464 - 471
Database
ISI
SICI code
0006-291X(19990802)261:2<464:TPISAU>2.0.ZU;2-0
Abstract
Phosphorylation of p53 at serine 389 has been shown to be responsive unique ly to UV but not gamma irradiation. This report describes identification of the UV-responsive p38MAPK protein as a serine 389 kinase. The immunoprecip itated p38MAPK from UV-irradiated murine embryonic testicular carcinoma F9 cells phosphorylated the serine 392 residue but not serine 15 of the human p53 protein in vitro and this phosphorylation was inhibited by a p38MAPK-sp ecific chemical inhibitor SB203580. The inhibitor also remarkably alleviate d the UV-caused induction and serine 389 but not serine 15 phosphorylation of the murine p53 protein in vivo. Subsequently, this compound suppressed t ranscriptional activity of p53 and partially retarded UV-induced apoptosis. Moreover, p53 bound to p38 as revealed by immunoprecipitation with anti-p5 3 antibodies from UV-treated F9 cells. Thus, these results suggest that UV- stimulated p53 phosphorylation at serine 389 is mediated by the stress-resp onsive p38MAPK. (C) 1999 Academic Press.